BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33516665)

  • 1. BAP1 antagonizes WWP1-mediated transcription factor KLF5 ubiquitination and inhibits autophagy to promote melanoma progression.
    Jia X; Chen H; Ren Y; Dejizhuoga ; Gesangyuzhen ; Gao N; Feng H; Huang W; Liao Y; Yu H
    Exp Cell Res; 2021 May; 402(1):112506. PubMed ID: 33516665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
    Zhao D; Zhi X; Zhou Z; Chen C
    Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.
    Qin J; Zhou Z; Chen W; Wang C; Zhang H; Ge G; Shao M; You D; Fan Z; Xia H; Liu R; Chen C
    Nat Commun; 2015 Sep; 6():8471. PubMed ID: 26419610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells.
    Chen C; Sun X; Guo P; Dong XY; Sethi P; Cheng X; Zhou J; Ling J; Simons JW; Lingrel JB; Dong JT
    J Biol Chem; 2005 Dec; 280(50):41553-61. PubMed ID: 16223724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAP1 promotes viability and migration of ECA109 cells through KLF5/CyclinD1/FGF-BP1.
    Wang F; Luo M; Qu H; Cheng Y
    FEBS Open Bio; 2021 May; 11(5):1497-1503. PubMed ID: 33529461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Catulin promotes cancer stemness by antagonizing WWP1-mediated KLF5 degradation in lung cancer.
    Tung CH; Huang MF; Liang CH; Wu YY; Wu JE; Hsu CL; Chen YL; Hong TM
    Theranostics; 2022; 12(3):1173-1186. PubMed ID: 35154481
    [No Abstract]   [Full Text] [Related]  

  • 7. BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN.
    Deng R; Guo Y; Li L; He J; Qiang Z; Zhang H; Chen R; Wang Y; Zhao X; Yu J
    Mol Oncol; 2021 Jan; 15(1):279-298. PubMed ID: 33155366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.
    Matatall KA; Agapova OA; Onken MD; Worley LA; Bowcock AM; Harbour JW
    BMC Cancer; 2013 Aug; 13():371. PubMed ID: 23915344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of miR-138 in patients with malignant melanoma through targeting of PDK1 in the PI3K/AKT autophagy signaling pathway.
    Meng F; Zhang Y; Li X; Wang J; Wang Z
    Oncol Rep; 2017 Sep; 38(3):1655-1662. PubMed ID: 28731179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5).
    Ge F; Chen W; Qin J; Zhou Z; Liu R; Liu L; Tan J; Zou T; Li H; Ren G; Chen C
    Oncotarget; 2015 Aug; 6(25):21369-78. PubMed ID: 26079537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasomal degradation of the KLF5 transcription factor through a ubiquitin-independent pathway.
    Chen C; Zhou Z; Guo P; Dong JT
    FEBS Lett; 2007 Mar; 581(6):1124-30. PubMed ID: 17320083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma.
    Webster JD; Pham TH; Wu X; Hughes NW; Li Z; Totpal K; Lee HJ; Calses PC; Chaurushiya MS; Stawiski EW; Modrusan Z; Chang MT; Tran C; Lee WP; Chalasani S; Hung J; Sharma N; Chan S; Hotzel K; Talevich E; Shain A; Xu M; Lill J; Dixit VM; Bastian BC; Dey A
    Pigment Cell Melanoma Res; 2019 Mar; 32(2):269-279. PubMed ID: 30156010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1.
    He M; Chaurushiya MS; Webster JD; Kummerfeld S; Reja R; Chaudhuri S; Chen YJ; Modrusan Z; Haley B; Dugger DL; Eastham-Anderson J; Lau S; Dey A; Caothien R; Roose-Girma M; Newton K; Dixit VM
    Science; 2019 Apr; 364(6437):283-285. PubMed ID: 31000662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
    Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
    J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCM7 silencing promotes cutaneous melanoma cell autophagy and apoptosis by inactivating the AKT1/mTOR signaling pathway.
    Yang Y; Ma S; Ye Z; Zhou X
    J Cell Biochem; 2020 Feb; 121(2):1283-1294. PubMed ID: 31535400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5.
    Nakajima Y; Akaogi K; Suzuki T; Osakabe A; Yamaguchi C; Sunahara N; Ishida J; Kako K; Ogawa S; Fujimura T; Homma Y; Fukamizu A; Murayama A; Kimura K; Inoue S; Yanagisawa J
    Sci Signal; 2011 Apr; 4(168):ra22. PubMed ID: 21487105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of WWP1-mediated ubiquitination modification affecting proliferation and invasion/migration of liver cancer cells.
    Zhang C; Wang W; Wu B
    Kaohsiung J Med Sci; 2024 Mar; 40(3):255-268. PubMed ID: 37997542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor Krüppel-like factor 5 promotes cell growth and metastasis via activating PI3K/AKT/Snail signaling in hepatocellular carcinoma.
    An T; Dong T; Zhou H; Chen Y; Zhang J; Zhang Y; Li Z; Yang X
    Biochem Biophys Res Commun; 2019 Jan; 508(1):159-168. PubMed ID: 30473218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways.
    Chen XX; Yin Y; Cheng JW; Huang A; Hu B; Zhang X; Sun YF; Wang J; Wang YP; Ji Y; Qiu SJ; Fan J; Zhou J; Yang XR
    Cell Death Dis; 2018 Oct; 9(10):1036. PubMed ID: 30305612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.